Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02283177
Title A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Arog Pharmaceuticals LLC

acute myeloid leukemia


Crenolanib + Cytarabine + Daunorubicin

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center Duarte California 91010 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Weill Cornell Medical College New York New York 10065 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from for the field